This may slightly delay the onset of noticeable weight loss but does not affect long-term outcomes
The highly coveted medication belongs to the same class of drug as diabetes medication Ozempic, which is also known for its weight loss side effects.
The gastrointestinal data paints a clear dose-dependent picture
Approved Semaglutide Peptide (CAS: 910463-68-2) Based Medications Benefits of Semaglutide Peptide (NN9535) Compared to Other GLP-1 Analogues (e.g., Liraglutide, Dulaglutide) Extended half-life (7 days): Allows convenient once-weekly dosing, unlike native GLP-1 or other analogues (e.g., liraglutide) that require more frequent administration
Side effects linked to collagen loss and facial morphology changes: Skin laxity Write-off of subcutaneous fat results in droop and folds, particularly in cheeks, jowls, and neck
Greater efficacy comes at the cost of greater side effect burden for some users